Trials / Completed
CompletedNCT05679375
IV and Intrathecal Ketamine in Cesarean Section
Comparison Between the Analgesic Effects of Intrathecal Versus Intravenous Ketamine After Spinal Anaesthesia for Elective Caesarean Delivery :a Randomised Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
In the current study, the investigators will compare the effects of low-dose intravenous (i.v.) ketamine versus intrathecal Ketamine added to spinal anesthesia on the time to first request for analgesia and maternal pain scores and overall satisfaction in patients undergoing cesarean section.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intrathecal ketamine | Patients will receive intrathecal Ketamine 0.1mg/kg added to bupivacaine and morphine |
| DRUG | Intravenous ketamine | Patients will receive IV Ketamine 0.25mg/kg after spinal |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2024-10-31
- Completion
- 2024-10-31
- First posted
- 2023-01-11
- Last updated
- 2025-03-06
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05679375. Inclusion in this directory is not an endorsement.